Search results
-
Blog
Participant Retention Strategies in Phase I Clinical Trials
Learn some of the key strategies Altasciences employs to ensure you have the participants you need for your studies.
-
Blog
Clinical and Regulatory Considerations for Developing COVID-19 Treatments – a Discussion with our Experts
As the COVID-19 pandemic evolves across the globe, the search for effective therapies also continues to gain momentum, including the possibility of repurposing existing medications that may show effectiveness against COVID-19 symptoms.